ATRA compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

ATRAAtara Biotherapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

ATRAAtara Biotherapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

ATRAAtara Biotherapeutics, Inc.

8.02▼−2.20%

Mkt cap$82.3MRevenue$630,000Q2 FY26Revenue$121MFY25

AMGNAmgen Inc

474.14▲+2.79%

Regular sessionNov 4 '26

Mkt cap$249.4BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Regular sessionNov 4 '26

ATRAAtara Biotherapeutics, Inc.

AMGNAmgen Inc

8.02▼−2.20%

Price

474.14▲+2.79%

$82.3M

Mkt cap

$249.4B

Q2 FY26$630,000

Revenue

$10.4BQ3 FY26

FY25$121M

Revenue

$36.8BFY25

ATRA8.02▼−2.20%vsAMGN474.14▲+2.79%Regular sessionNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ATRA: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ATRA 5

—FUJIFILM Diosynth Biotechnologies California, Inc. (FDB)unlistedsupplier

—Memorial Sloan Kettering Cancer Center (MSK)unlistedsupplier

—QIMR Berghoferunlistedsupplier

—HCR Molag Fund L.P. (HCRx)unlistedcustomer

1 more · ATRA chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

Price

rebased to 0%

ATRA, solidAMGN, dashed